• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 19G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 19G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/24/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported "attending peds on day unit for treatment accompanied by mother.Ivad had been accessed previously on february 17th for ongoing treatment.The nurse caring for the patient assessed the line prior to giving chemotherapy by checking for blood return and noted that only air returned in the syringe, no blood return or fluid return; suspected invisible break in line.Break in tubing verified once the affected huber needle was removed and examined.The break was found where the microbore tubing of the ivad needle extension set meets the light blue luer connection." it was stated this occurred two times.This report addresses the first device.
 
Additional Manufacturer Narrative
The manufacturer has received the sample and will evaluate.Results are expected soon.A lot history review (lhr) of asezf117 showed one other similar product complaint(s) from this lot number.The complaints for this lot number (asezf117) have been reported from the same facility in (b)(6).
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, trend analysis, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a damaged infusion set was confirmed and the cause is currently under investigation.The product returned for evaluation was one 19ga x 0.75" powerloc max safety infusion set.The returned product sample was evaluated and the following observations were made: a tear in the extension tube was seen at the interface of the proximal luer adapter the fracture surfaces of the damage contained striation-like patterns, radiating tear marks and material buckling which were indicative of flexural fatigue based failures, which may have been a contributing factor to the extension tubing damage.Repetitive mechanical stresses such as twisting and kinking may have contributed to the observed event; however, it appeared that additional unidentified factors also contributed.The device is a supplied component and the supplier has been notified of this event.H3 other text: evaluation findings are in section h.11.
 
Event or Problem Description
It was reported "attending peds on day unit for treatment accompanied by mother.Ivad had been accessed previously on (b)(6) for ongoing treatment.The nurse caring for the patient assessed the line prior to giving chemotherapy by checking for blood return and noted that only air returned in the syringe, no blood return or fluid return; suspected invisible break in line.Break in tubing verified once the affected huber needle was removed and examined.The break was found where the microbore tubing of the ivad needle extension set meets the light blue luer connection." it was stated this occurred two times.This report addresses the first device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC MAX POWER-INJECTIBLE INFUSION SET 19G X 0.75IN
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer Contact
johanna de oliveira
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key14398208
Report Number3006260740-2022-01777
Device Sequence Number5326079
Product Code FPA
UDI-Device Identifier00801741047435
UDI-Public(01)00801741047435
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K153440
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number0141975
Device Lot NumberASEZF117
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/26/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/09/2022
Supplement Date Received by Manufacturer06/22/2022
Initial Report FDA Received Date05/13/2022
Supplement Report FDA Received Date08/17/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/01/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-